VitalCare Offers Licenses for Diabetes Treatment Centers

CARSON CITY, Nev.--(EON:Enhanced Online News)--VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI), a Nevada corporation, today announced it will offer licenses in select markets for Diabetes Treatment Centers.

“This is a unique opportunity for all those in the medical field who really want to make a difference in the lives of patients with Type 1 and Type 2 diabetes. The results of iCAT Therapy are well documented and speak for themselves.”

The license will allow qualified professionals to administer the highly successful iCAT Therapy to patients with Type 1 and Type 2 diabetes. VitalCare will offer complete setup and training to all personnel at each center with a comprehensive ongoing support program. Licenses will also be offered to qualified medical groups and HMOs.

Jimmy McDougald, CEO of VitalCare, stated, “This is a unique opportunity for all those in the medical field who really want to make a difference in the lives of patients with Type 1 and Type 2 diabetes. The results of iCAT Therapy are well documented and speak for themselves.”

About VitalCare Diabetes Treatment Centers, Inc.

VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge" medical devices and healthcare services direct to consumers, focusing on an emerging FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as “Intracellular Activation Therapy (iCAT).”

Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.’s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.’s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCare’s filings with the Securities and Exchange Commission.

View All Releases from This Organization